Hans Paul Walliser
Nessuna posizione attualmente
Profilo
Hans Paul Walliser worked as a Director of Biopharma Management Services at GE Healthcare Bio-Sciences, Technical Director at Vivendy Therapeutics Ltd., and Managing Director at Exyte Central Europe GmbH.
He also worked as a Principal at Novartis AG.
Walliser holds a doctorate degree from the University of Basel.
Precedenti posizioni note di Hans Paul Walliser
| Società | Posizione | Fine |
|---|---|---|
Vivendy Therapeutics Ltd.
 Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Vivendy Therapeutics Ltd. develops enzyme replacement therapy and biological products. It has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity-enhancing the efficacy of the therapy in MPS IVA significantl. The company was founded in March 2006 and is headquartered in Basel, Switzerland. | Direttore Tecnico/Scientifico/R&S | 10/03/2014 |
GE Healthcare Bio-Sciences
 GE Healthcare Bio-Sciences Medical/Nursing ServicesHealth Services GE Healthcare Bio-sciences provides health care services. It makes purification systems that allow for the development of effective drugs through protein analysis, DNA sequencing and genetic variation. GE Healthcare Bio-sciences is headquartered in Little Chalfont, UK. | Corporate Officer/Principal | - |
Exyte Central Europe GmbH
 Exyte Central Europe GmbH Engineering & ConstructionIndustrial Services Exyte Central Europe GmbH engages in the planning and construction of processing plants and buildings. It also provides consulting, design, implementation, qualification and validation, as well as technical facility management services. The company was founded in 1995 and is headquartered in Stuttgart, Germany. | Presidente | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Formazione di Hans Paul Walliser
| University of Basel | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Aziende private | 3 |
|---|---|
GE Healthcare Bio-Sciences
GE Healthcare Bio-Sciences Medical/Nursing ServicesHealth Services GE Healthcare Bio-sciences provides health care services. It makes purification systems that allow for the development of effective drugs through protein analysis, DNA sequencing and genetic variation. GE Healthcare Bio-sciences is headquartered in Little Chalfont, UK. | Health Services |
Vivendy Therapeutics Ltd.
Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Vivendy Therapeutics Ltd. develops enzyme replacement therapy and biological products. It has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity-enhancing the efficacy of the therapy in MPS IVA significantl. The company was founded in March 2006 and is headquartered in Basel, Switzerland. | Health Services |
Exyte Central Europe GmbH
Exyte Central Europe GmbH Engineering & ConstructionIndustrial Services Exyte Central Europe GmbH engages in the planning and construction of processing plants and buildings. It also provides consulting, design, implementation, qualification and validation, as well as technical facility management services. The company was founded in 1995 and is headquartered in Stuttgart, Germany. | Industrial Services |
- Borsa valori
- Insiders
- Hans Paul Walliser
